Objective: Schizophrenia (SZ) patients have information processing deficits, spanning from low level sensory processing to higher-order cognitive functions. Mismatch negativity (MMN) and P3a are eventrelated potential (ERP) components that are automatically elicited in response to unattended changes in ongoing, repetitive stimuli that provide a window into abnormal information processing in SZ. MMN and P3a are among the most robust and consistently identified deficits in SZ, yet the neural substrates of these responses and their associated deficits in SZ are not fully understood. This study examined the neural sources of MMN and P3a components in a large cohort of SZ and nonpsychiatric control subjects (NCS) using Exact Low Resolution Electromagnetic Tomography Analyses (eLORETA) in order to identify the neural sources of MMN and P3a as well as the brain regions associated with deficits commonly observed among SZ patients. Methods: 410 SZ and 247 NCS underwent EEG testing using a duration-deviant auditory oddball paradigm (1-kHz tones, 500 ms SOA; standard p = 0.90, 50-ms duration; deviant tones P = 0.10, 100-ms duration) while passively watching a silent video. Voxel-by-voxel within-(MMN vs. P3a) and between-group (SZ vs. NCS) comparisons were performed using eLORETA. Results: SZ had robust deficits in MMN and P3a responses measured at scalp electrodes consistent with other studies. These components mapped onto neural sources broadly distributed across temporal, frontal, and parietal regions. MMN deficits in SZ were associated with reduced activations in discrete medial frontal brain regions, including the anterior-posterior cingulate and medial frontal gyri. These early sensory discriminatory MMN impairments were followed by P3a deficits associated with widespread reductions in the activation of attentional networks (frontal, temporal, parietal regions), reflecting impaired orienting or shifts of attention to the infrequent stimuli. Conclusions: MMN and P3a are dissociable responses associated with broadly distributed patterns of neural activation. MMN deficits among SZ patients appear to be primarily accounted for by reductions in medial prefrontal brain regions that are followed by widespread dysfunction across cortical networks associated with P3a in a manner that is consistent with hierarchical information processing models of cognitive deficits in SZ patients. Impairments in automatic stimulus discrimination may contribute to higher-order cognitive and psychosocial deficits in SZ.
Introduction
Schizophrenia patients exhibit neurocognitive deficits across multiple domains, from the earliest levels of sensory information processing (Braff, 1989; Grillon et al., 1990; Light and Braff, 2005a,b; Shelley et al., 1991) through progressively higher-order cognitive domains including attention, memory, language, and social functioning (e.g. Heaton et al., 2001; Light and Braff, 2005a,b; . Some neurophysiological measures probe the earliest stages of cognition, are automatically NeuroImage 66 (2013) [594] [595] [596] [597] [598] [599] [600] [601] [602] [603] ☆ Disclosure of financial relationships: Dr. Light has received compensation from Astellas for one-time participation in a scientific advisory board meeting unrelated to this study. The remaining authors report no financial relationships with commercial interests.
elicited, and require little or no effort, attention, engagement, or even awareness on the part of the subject (Braff and Light, 2004; Callaway and Naghdi, 1982; Näätänen, 1992) . Deficits in these early stages of sensory information processing may underlie some clinical symptoms in schizophrenia (Fisher et al., 2008; Ford et al., 2007; Mathalon and Ford, 2008) , and may govern deficits in more complex cognitive operations and real-world psychosocial functioning of schizophrenia patients (Braff and Light, 2004; Rissling et al., in press; Tiitinen et al., 1994) . The purpose of the current study was to employ novel computational imaging analyses in order to identify the neural substrates of normal and impaired preattentive sensory discrimination in a large cohort of nonpsychiatric control subjects and schizophrenia patients.
Scalp-recorded event-related potential (ERP) measures are often used to reliably quantify the neural processing associated with sensory and cognitive events with millisecond (ms) resolution. Although the spatial resolution of EEG measures has traditionally been less precise than functional magnetic resonance imaging, novel analytic techniques can now be used to elucidate the contribution of distributed neuroanatomic sources to scalp-recorded ERP components (Makeig et al., 1997 (Makeig et al., , 2004 Pascual-Marqui, 2002 Pascual-Marqui et al., 1994 Rissling et al., 2010) .
The auditory mismatch negativity (MMN) is a negative-going deflection in the ERP that is evoked when a sequence of repetitive "standard" stimuli is occasionally interrupted by infrequent oddball or "deviant" stimuli that differ in some stimulus characteristic such as duration or pitch. The onset of the MMN response occurs within 50 ms of stimulus deviance, and peaks after an additional 100-150 ms. Since MMN requires no overt behavioral response and can be elicited even in the absence of directed attention (Näätänen, 1992; Rinne et al., 2001; Sussman et al., 2003) , it is presumed to reflect a predominantly automatic, pre-conscious process of detecting a "mismatch" between the deviant stimulus and a sensory-memory trace .
The MMN response is followed by a positive-going ERP deflection peaking at 250-300 ms after stimulus onset (Alho et al., 1997; Paavilainen et al., 1989) . This "P3a" component is thought to reflect a reorienting or covert shifting of attention (Friedman et al., 2001; Polich, 2007; Squires et al., 1975) . Since both MMN and P3a are elicited even in the absence of directed attention, these measures are often used to assess impairments in the initial stages of cognitive information processing and are presumed to be relatively immune to interference from inattentiveness, incomplete effort or engagement . These aspects of the MMN and P3a are thought to be strengths given that inattentiveness and incomplete effort can confound the assessment of some higher cognitive operations among SZ patients.
Many studies have demonstrated that MMN and P3a are reduced in SZ patients (Michie, 2001; Turetsky et al., 2007; Umbricht and Krljes, 2005) with distinct relationships to important demographic, clinical, and functional characteristics which suggests that these measures index discrete processes with dissociable underlying neural substrates .
MMN fulfills criteria for use as an endophenotypic marker (Gottesman and Gould, 2003) of the disease since it is: (a) associated with SZ (Umbricht and Krljes, 2005) ; (b) heritable (Hall et al., 2006; Price et al., 2006) ; (c) independent of fluctuations of clinical state and symptoms Shinozaki et al., 2002); present in individuals at genetic risk for developing schizophrenia (Atkinson et al., 2012; Baker et al., 2005; Jahshan et al., 2012; Jessen et al., 2001; Michie et al., 2002; Schreiber et al., 1992) . Furthermore, MMN may also serve as a biomarker of treatment response in clinical trials, because it is: (e) extremely reliable in both normal individuals and schizophrenia patients tested over a 1-year interval ; (f) insensitive to order or practice effects (Kathmann et al., 1999; Pekkonen et al., 1995) ; (g) robustly related to level of everyday functioning in schizophrenia patients (Friedman et al., 2012; Kawakubo et al., 2007; Kiang et al., 2007; Light and Braff, 2005a,b; Rasser et al., 2011; Wynn et al., 2010 ) (h) responsive to pharmacologic models of schizophrenia (Javitt et al., 1996; Lavoie et al., 2008; Umbricht et al., 2000 Umbricht et al., , 2002 ; and (i) easily assessed in patients with a broad range of function given the low effort associated with task demands. On the basis of these features, Belger and colleagues (Belger et al., 2012) argued that MMN may be the biomarker "we've been waiting for" since it represents a unique window into disturbed central auditory processing in schizophrenia and related conditions as reviewed by Näätänen et al. (2012) . Though the P3a has not been studied as extensively as MMN, studies have shown robust and reliable amplitude deficits in schizophrenia patients comparable in magnitude to MMN (A.J. Rissling et al., in press; Grillon et al., 1990; Jahshan et al., 2012; Kiang et al., 2009; Mathalon et al., 2000; Turetsky et al., 1998) . Thus, P3a may also serve as a useful biomarker in clinical research studies of schizophrenia (Javitt et al., 2008; Light et al., 2012) .
While many studies have demonstrated the substantial utility of MMN and P3a in SZ research, typically only the latency and amplitude at selected electrodes (e.g., Fz) and singular time points are used to characterize these neural responses. The measurement of ERP peak voltage may not fully capture the complexity of neural processing that underlies these sensory-based cognitive processes. Multi-sensor EEG data allows for the spatio-temporal quantification of these responses (Hamm et al., in press) as well as the identification of the neural architecture that underlies normal and abnormal scalprecorded ERPs. Unfortunately, a significant gap exists in the MMN/ P3a literature: relatively few studies have examined the neural sources of MMN and P3a in normal subjects or the regions that prominently contribute to the deficits observed in schizophrenia. Previous MEG, fMRI, and intracranial animal studies of MMN sources have consistently identified generators in the primary and secondary auditory cortices resulting in the common assumption that schizophreniarelated deficits in these measures arise from impaired activation in temporal structures (e.g., see Figure 1 in Umbricht and Krljes, 2005) . In contrast, surface and intracranial EEG, PET, and fMRI studies (reviewed by Schönwiesner et al., 2007) suggest additional contributions from frontal regions such as the inferior frontal gyrus (Marco-Pallares et al., 2005; Park et al., 2002; Rinne et al., 2000; Schönwiesner et al., 2007) , medial frontal gyrus (Marco-Pallares et al., 2005; Restuccia et al., 2005) , and anterior cingulate cortex (Jemel et al., 2002; Oknina et al., 2005; Waberski et al., 2001; Wild-Wall et al., 2005) . Notably, the contribution of parietal cortices to MMN has also been observed (Kasai et al., 1999; Lavikainen et al., 1995; Levänen et al., 1996; Molholm et al., 2005; Schall et al., 2003) , although it is possible that the observed parietal involvement may have been related to the subsequent generation of the P3a rather than MMN. Thus, clarification of the neural sources of MMN and P3a generation is an important step in the elucidation of SZ-related deficits in sensory discriminatory processes.
Since the brain activity of MMN and P3a is spatially distributed and not confined to single point sources, a distributed EEG/MEG tomography may offer some advantages over some traditional methods of dipole fitting. To address this limitation, Low Resolution Electromagnetic Tomography (LORETA; publicly available free academic software at http://www.uzh.ch/keyinst/loreta.htm) algorithms based on discrete, three-dimensional (3D) distributed, linear, minimum norm inverse solutions have been developed for the examination of neural activity. Recently, the LORETA methods have been refined via standardized (i.e., sLORETA) and exact (i.e., eLORETA) procedures that can correctly localize deep structures such as the anterior cingulate cortex (Pizzagalli et al., 2001) , and mesial temporal lobes (Zumsteg et al., 2006a) , which may be under-recognized using other localization procedures.
Previous LORETA-based studies of healthy normal subjects support the role of temporal (Laufer and Pratt, 2005 (Fisher et al., 2008; Park et al., 2002) , though neither the neural sources of P3a nor the brain regions specifically associated with SZ deficits have been reported. Park et al. (2002) observed significantly deactivated areas of MMN sources elicited in response to pitchdeviant oddball stimuli in schizophrenia patients (N=14) compared with normal controls (N= 14) at the left superior temporal gyrus and the left inferior parietal lobule. In contrast, Fisher and colleagues (Fisher et al., 2008) employed frequency, duration, intensity, location and gap deviants to investigate MMN generators in 12 hallucinating and 12 non-hallucinating SZ patients relative to 12 NCS, but failed to detect significant differences in the current density distributions between groups with any of the deviant types. The inconsistencies of results could be attributable to differences in the stimulation and recording parameters, small sample sizes yielding low statistical power for detecting deficits, and potential differences in the clinical characteristics of the patient cohorts. In addition, recent advances in EEG-based source localization methodology offer substantial improvements in accuracy over previous tomographies.
The aims of the present study were to characterize the neural sources of MMN and P3a as well as to identify the areas associated with SZ-related deficits in these measures. Secondary analyses included testing whether SZ deficits in MMN and P3a reflect divergent pathophysiological processes with distinct neural sources. We hypothesized that MMN and P3a will have partially overlapping neural sources across temporal and frontal brain regions with schizophrenia related deficits arising from impaired activation of these networks.
Methods

Participants
Participants included a large cohort of 410 schizophrenia patients and 247 nonpsychiatric control subjects (NCS), described in , which focused on scalp ERP analyses primarily from Fz and Cz electrodes. Patients were outpatients recruited from community residential facilities. NCS were recruited through newspaper advertisements, postings on the internet, and flyers posted at the University of California, San Diego (UCSD) Medical Center. All participants were assessed on their capacity to provide informed consent and, after they were given a detailed description of the study, provided written informed consent via the UCSD Institutional Review Board approved consent form (IRB numbers 020394, 030510, 040564, and 071831). All participants received a urine toxicology screen to rule out recent drug use.
Patients were assessed diagnostically using the Structured Clinical Interview for DSM-IV (SCID) and were screened to rule out any other Axis I diagnosis including substance abuse or dependence within the past 6 months. NCS were also assessed using the SCID (non-patient edition) to rule out any past or present Axis I (First et al., 1996) or Axis II (cluster A) (First et al., 1996) diagnoses including substance abuse or dependence within the past 6 months. Exclusion criteria for both schizophrenia patients and nonpsychiatric controls also included any current or past neurologic insult such as significant head trauma and/or loss of consciousness in accordance with our established screening methods (Light and Braff, 2005a,b; Light et al., 2006; Swerdlow et al., 2006) . Audiometric testing (model SCR2; Saico, Assens, Denmark) was used to ensure that all participants had normal hearing and were able to detect 40-dB tones at 1000 Hz. Table 1 shows the demographic data of subjects. The age of the schizophrenia patients and nonpsychiatric controls were comparable. Schizophrenia patients completed significantly fewer years of formal education compared with the nonpsychiatric controls (t=16.04, df= 491.2, p b 0.001). There were more males in patient group compared with control group (χ 2 = 42.06, df= 1.0, p b 0.001). All patients were clinically stable with most prescribed combination of psychotropic and nonpsychotropic medications. The majority of patients were prescribed second-generation antipsychotic medications (N= 297), 24 patients were prescribed first-generation antipsychotics, and 65 patients were prescribed a combination of first-and second-generation antipsychotics. Twenty-four patients were not taking any antipsychotics. Clinical symptoms were assessed using the Scale for the Assessment of Negative Symptoms (SANS; Andreasen, 1984) and the Scale for the Assessment of Positive Symptoms (SAPS; Andreasen, 1984) . A modified Global Assessment of Functioning (GAF) Scale was used to assess functional status (Hall, 1995) . 185 patients were living in board-and-care facilities; 225 patients were living independently or with their family at the time of testing. Patients were diagnosed as having the following subtypes: paranoid (n=192), disorganized (n= 20), undifferentiated (n=136), and residual (n= 62).
Stimulus characteristics and test paradigm
The MMN and P3a of the scalp-recorded ERPs were elicited and recorded according to the procedures detailed in . Participants were presented with binaural tones (1-kHz computer-generated square-wave stimuli, 85 dB[A] sound pressure level [SPL] , 1 ms rise/fall) with a fixed stimulus onset-to-onset asynchrony of 500 ms using a stimulus senerating unit (SR-HLAB; San Diego Instruments, Inc., San Diego, CA). Standard (P = 0.90, 50-ms duration) and deviant (P = 0.10, 100-ms duration) tones were presented in pseudorandom order through foam insert earphones (Model 3A, Aearo Company Auditory Systems, Indianapolis, Ind).
During the approximately 20-to 25-min electroencephalographic recording session, participants watched a silent, benign, cartoon video to divert attention from the tones, minimize boredom, and reduce eye movements. Subjects were instructed to pay careful attention to the video as they may be asked questions about it at the end of testing. Subjects were continuously monitored through a 1-way mirror, and short breaks were offered to ensure alertness and comfort during the recording session. This paradigm has been extensively validated in our laboratory and yields 1-year stability coefficients for MMN and P3a in the 0.90 range in both SZ patients and NCS .
Electroencephalographic recording
Electroencephalograph (EEG) data acquisition, stimulation, and processing was performed in accordance with previously published methods (Light and Braff, 2005a,b; The EEG was recorded from the scalp, through sintered Ag/AgCl electrodes embedded in an electrode cap (EasyCap, Falk Minow Services, HerrschingBreitbrunn, Germany) at the following equidistant electrode positions: Fp1, Fp2, Fz, F3, F4, F7, F8, FC1, FC2, FC5, FC6 , Cz, C3, C4, CP1, CP2, CP5, CP6, Pz, P3, P4, P7, P8, O1, O2, PO9, PO10, Iz, T1, T2, T7, T8, TP9, and TP10. Electrodes placed at the nose tip and at Fpz served as reference and ground, respectively. Four additional electrodes placed above and below the left eye and at the outer canthi of both eyes were used for monitoring blinks and eye movements. All impedances were below 4 kΩ. Signals were digitized at the rate of 1 kHz, with system acquisition filter settings at 0.5-100 Hz. The EEG and stimulus markers were recorded continuously. During testing, online event-related potential (ERP) averages to standard and deviant tones were also monitored to ensure signal quality and to track the number of trials free of gross artifact (±100 μV across the −100 to 500 ms following stimuli onset). EEG acquisition was terminated when a minimum of 225 artifact-free deviant trials were collected. No participant required presentation of more than 300 deviant tones in order to achieve 225 artifact-free epochs during acquisition. Data processing was performed offline and blind to group membership using semi-automated procedures. First, continuous EEG recordings were examined to remove either bad electrodes or segments of the recordings that were characterized by excessive artifact. The recordings were then mathematically corrected for eye movement artifact using established methods (Semlitsch et al., 1986) . Continuous data were divided into epochs relative to the onset of stimuli (−100 to 500 ms), with mean voltage of the prestimulus interval used as baseline. Following blink correction, epochs with activity that exceeded ±100 μV in any electrode were excluded from further processing. Next, additional processing was performed to in order to minimize residual ocular artifact by excluding trials from frontal recording sites (F7, F8, Fp1, Fp2, F3, F4, and Fz) with activity ±50 μV. Following all artifact correction/rejection procedures, NCS and SZ patients had an average of 272 and 265 artifact-free deviant trials, respectively.
In this paradigm, a difference ERP was formed by subtracting the average ERP to standard stimuli from the average ERP to deviant stimuli. This difference waveform removes common obligatory ERP components (i.e., P50, N1) that reflect sensory registration common to both the standard and deviant averages and therefore represents sensory discriminatory processing. The resultant difference waves were low-pass filtered at 20 Hz (0-phase shift, 24 dB/octave roll-off). In addition, butterfly and mean global field power plots (Fig. 1) were visually inspected to ensure that all participants had ERP responses that were at least 2× the amplitude of the prestimulus baseline and to remove data from faulty sensors. The peak latencies and mean amplitudes of MMN and P3a were calculated across the 135-to 205-ms and 250-to 300-ms latency ranges, respectively, of the difference ERP, consistent with established methods (Kiang et al., 2007; Light and Braff, 2005a,b; Light et al., 2007; Michie et al., 2002) .
Source-localization analysis
Based on the scalp-recorded electric potential distribution, the Exact Low Resolution Electromagnetic Tomography Analyses (eLORETA) software was used to compute the cortical three-dimensional distribution of electric neuronal activity. The original LORETA method (PascualMarqui et al., 1994 ) has received considerable validation from studies combining EEG/MEG source localizations performed in conjunction with other more established localization methods, such as functional Magnetic Resonance Imaging (fMRI; Mulert et al., 2004; Vitacco et al., 2002) , structural MRI (Worrell et al., 2000) , and Positron Emission Tomography (PET; Dierks et al., 2000; Pizzagalli et al., 2003; Zumsteg et al., 2005) . Findings using LORETA have also been validated by recordings from implanted depth electrodes during intraoperative studies of epilepsy patients (Zumsteg et al., 2006a (Zumsteg et al., ,2006b (Zumsteg et al., ,2006c and from data using cognitive ERPs (Volpe et al., 2007) . More recently, the LORETA methods have been refined via standardized (i.e., sLORETA) and exact (i.e., eLORETA) localization procedures.
In the case of sLORETA (Pascual-Marqui, 2002) , two independent research groups (Greenblatt et al., 2005; Sekihara et al., 2005) have demonstrated that the method has no localization bias in the absence of measurement noise; but in the presence of measurement noise a localization bias was reported. However under arguably more realistic conditions (in the presence of both biological and measurement noise), Pascual-Marqui (2007) demonstrated no localization bias with sLORETA. Furthermore, sLORETA (Pascual-Marqui, 2002) has been validated in several simultaneous EEG/fMRI (Mobascher et al., 2009; Olbrich et al., 2009) , EEG/structural MRI (Betting et al., 2010) , EEG localization in epilepsy, and in an EEG/PET (Laxton et al., 2010) study. Further LORETA has been validated both in theory and in practice, the latter relying on experimental data for which the true generators (i.e., "ground truth") are known from invasive, implanted depth electrodes, in studies in epilepsy (Zumsteg et al., 2006a,b,c) and cognitive ERPs (Volpe et al., 2007) . These results also serve as validation for the improved localization properties of eLORETA. The technical details of the method, including theoretical proof for its exact localization properties, the particular weights used, its validation, and comparisons to other source localization techniques can be found in the literature (Pascual-Marqui, 2007 Pascual-Marqui et al., 2011) . Therefore, eLORETA provides a useful analytic platform for examination of the neural sources associated with MMN and P3a.
Computations were made in eLORETA using a realistic head model (Fuchs et al., 2002) , the MNI152 template (Mazziotta et al., 2001) with the three-dimensional solution space restricted to cortical gray matter as determined by the probabilistic Talairach atlas (Lancaster et al., 2000) . The standard electrode positions on the MNI152 scalp were taken from Jurcak et al. (2007) and Oostenveld and Praamstra (2001) . The intracerebral volume is partitioned in 6239 voxels at 5 mm spatial resolution. Thus, eLORETA images represent the electric activity at each voxel in neuroanatomic Montreal Neurological Institute (MNI) space as the magnitude of the estimated current density.
Statistical analyses
To determine whether ERP amplitudes differed between the patient and nonpsychiatric comparison groups independent t-tests (two-tailed with an α-level = 0.001) were conducted on MMN and P3a amplitudes at each electrode. An estimate of effect size (Cohen, 1988) was also calculated for all specific comparisons. The grand mean eLORETA images were computed by first calculating the eLORETA solution for each subject, and then averaging the current density values across all subjects for each group.
The eLORETA software package was used to perform the statistical analyses of the current density distribution (milliampere per millimeter squared, mA/mm2), including group comparison analysis. The methodology (Nichols and Holmes, 2002) used is non-parametric and based on estimating the empirical probability distribution of the max-statistic (e.g. the maximum of a t or an F statistic) under the null hypothesis via 5000 randomizations. This methodology corrects for multiple testing (i.e., for the collection of tests performed for all voxels, and for all time samples). Due to the non-parametric nature of the method, its validity need not rely on any assumption of Gaussianity. The time frames of interest for statistical imaging (MMN: 135-205 ms; P3a: 250-300 ms) were selected on the basis of prior conventional ERP analysis. The results correspond to maps of log-F-ratio statistics for each voxel, for corrected p b 0.001. Fig. 1 shows the butterfly plots, scalp topography, and mean global field power of grand average responses of NCS and schizophrenia patients. Independent t-tests revealed a broad, frontocentral distribution of the MMN and P3a deficits, with significant mean amplitude (p b 0.001) and effect size (Cohen's d > 0.8) differences between the NCS and schizophrenia patients detected at the following frontocentral electrodes for MMN: Fp1, Fp2, F7, F8, Fz, F3, F4, FC1 , FC2, FC5, FC6, C3, Cz, C4, CP1, CP2, CP6 and P3a: Fz, F3, F4, F8, FC1, FC2, FC5, FC6, C3 , Cz.
Results
Comparison of EEG results
Current density of mismatch negativity and P3a sources
In the control group, major generators of MMN were found at bilateral precentral gyrus, medial frontal gyrus, paracentral lobule, cingulate gyrus, and superior temporal gyrus, maximum at right precentral gyrus (Fig. 2a) . In the patient group, major generators of MMN were found at bilateral medial frontal gyrus, superior frontal gyrus, superior temporal gyrus, and anterior cingulate, maximum at left superior frontal gyrus (Fig. 2b) . Compared to the nonpsychiatric controls, schizophrenia patients had significantly smaller current density of MMN at right medial frontal gyrus, right cingulate gyrus, and right paracentral lobule with maximum group differences evident at the right medial frontal gyrus (log F = − 1.33023, p b 0.0002) and surrounding areas (Fig. 2c ). There were no locations where schizophrenia patients had significantly larger current densities compared with nonpsychiatric controls in MMN.
In the control group, major generators of P3a were identified at bilateral postcentral gyrus, paracentral lobule, and cingulate gyrus, also maximum at left medial frontal gyrus (Fig. 3a) . In the patient group, generators were identified in bilateral postcentral gyrus, paracentral lobule, medial frontal gyrus, cingulate gyrus, precentral gyrus, and superior frontal gyrus, maximum at left precentral gyrus (Fig. 3b) . In contrast to MMN, P3a group differences were evident across widespread areas spanning the frontal, temporal, and parietal lobes, including anterior cingulate, cingulate gyrus, parahippocampal gyrus, posterior cingulate, paracentral lobule, medial frontal gyrus, superior frontal gyrus, postcentral gyrus, inferior parietal lobule, precuneus, and sub-gyral with maximum deficits in schizophrenia patients at the right postcentral gyrus (log F = − 1.4773, p b 0.0002) and surrounding areas (Fig. 3c ). There were no locations where schizophrenia patients had significantly larger current densities compared with nonpsychiatric controls in P3a.
To investigate whether MMN and P3a are dissociable responses, MMN vs. P3a current densities were examined separately for nonpsychiatric controls and schizophrenia patients (Fig. 4) . In the control group, compared to MMN, P3a current density was significantly larger at bilateral cingulate gyrus, anterior cingulate, medial frontal gyrus, superior frontal gyrus, paracentral lobule, and postcentral gyrus with maximum group differences in right cingulate gyrus (log F=0.792, pb 0.0002) and surrounding areas. In the patient group, P3a current density was significantly larger than MMN density at cingulate gyrus, medial frontal gyrus, paracentral lobule, and superior frontal gyrus, compared to MMN with maximum group differences in the right cingulate gyrus (log F=0.776, pb 0.0002) and surrounding areas. There was no location where P3a current density was significantly smaller than MMN density in either patients or nonpsychiatric controls.
Discussion
This study examined the neural substrates of scalp-recorded MMN and P3a event-related potentials in a large cohort of schizophrenia patients and normal controls using Exact Low Resolution Electromagnetic Brain Tomography Analyses (eLORETA). Traditional scalp ERP analyses revealed robust MMN and P3a deficits in schizophrenia patients at frontocentral electrodes, consistent with many previous studies and detailed . Novel eLORETA analyses in this large sample of participants demonstrate that MMN and P3a measures of sensory discrimination and orienting of attention are supported by broadly distributed and overlapping neural sources across temporal, frontal, and parietal regions. Notably, the distribution of MMN and P3a neural sources was similar in both groups (Figs. 2 and  3) . In contrast to our expectations, reduced activation of sources in schizophrenia patients during automatic sensory discriminatory processing (i.e. MMN) were relatively constrained to discrete areas within medial frontal brain region (Fig. 2c) . Following sensory discrimination, deficits in the orienting/covert shifting of attention reflected by the P3a were exhibited by broadly distributed generalized deficits in activation across frontal, temporal, and parietal regions, potentially reflecting impaired activation of widespread attentional networks. This pattern of results suggests that the distributed neural architecture that supports initial auditory sensory discrimination (i.e., MMN) is similar in schizophrenia patients but the impairments in medial frontal regions cascade forward and devolve into generalized neurocognitive deficits (Braff and Light, 2004; Javitt, 2009; Rissling et al., 2010; Tiitinen et al., 1994) . The present results contribute to the growing literature suggesting that abnormal activation of medial frontal areas including the cingulate cortex and medial frontal gyrus are among the core neurophysiological features of schizophrenia accounting for several distinct cognitive deficits (e.g., Fujiwara et al., 2007) including the routine processing of simple, task irrelevant auditory tones as in the present study.
Increasingly, neurophysiological biomarkers of these processes are utilized in a variety of neuroscience research applications including as endophenotypes in genetic association studies (Force et al., 2008; Greenwood et al., 2007) , as targets for assessing drug response (Ehrlichman, et al., 2008) , for predicting response to pharmacologic and/or psychosocial treatments, and for tracking the emergence and progression of deficits across the course of illness (e.g., Jahshan, et al., 2012) . Although the MMN and P3a ERPs are automatically elicited as a response complex with a similar scalp distribution and magnitude of deficits, we have recently shown that these measures are statistically dissociable and represent unique impairments in schizophrenia patients . The eLORETA analyses in this paper also reveal the non-overlapping neural architecture of responses (Fig. 4) in both groups. The current results therefore support our previous view that MMN and P3a potentially reflect divergent pathophysiological processes and may differentially contribute to the commonly observed deficits in neurocognitive and psychosocial functioning.
As is often the case for the EEG and neuroimaging studies of schizophrenia, medications were not experimentally controlled in this study. Although no significant cross-sectional medication effects were detected in the scalp-recorded ERPs from this cohort as detailed in , the potential effects of medications on neural source activations have not been previously investigated. The substantial heterogeneity of antipsychotic and adjunctive treatments, variable degree of daily adherence to prescribed medication regimens, and multiple pathways to receiving prescriptions of particular drugs (e.g., insurance limiting access to specific drugs), does not lend itself to attempt to disentangle potential medication effects. Future prospective controlled studies with randomization are needed to clarify the potential impact of antipsychotic medications on neurophysiology.
Conclusions
MMN and P3a are dissociable responses supported by complex and distributed neural systems. MMN deficits in distinct medial frontal regions appear to cascade forward and produce dysfunction within widespread cortical networks in a manner consistent with hierarchical models of cognitive deficits in SZ patients (Rissling et al., in press; Braff and Light, 2004; Javitt, 2009 ). Impairments in automatic stimulus discrimination underlie deficits in some higherorder cognitive operations (e.g., Rissling et al., in press) that are necessary for navigation through complex environments and daily psychosocial functioning (Light and Braff, 2005a,b; Kawakubo and Kasai, 2006; Umbricht et al., 2006; Kawakubo et al., 2007; Butler et al., 2009; Leitman et al., 2010; Wynn et al., 2010; Rasser et al., 2011) . Future studies are needed to experimentally manipulate the activation of attentional networks and better understand contribution of sensory processing deficits in schizophrenia to the commonly observed impairments in cognitive psychosocial functioning in schizophrenia patients. 
